Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliana Guerrieri-Gonzaga

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Pigment Cell & Melanoma Research|October 11, 2012
Vitamin D and overall mortalityAliana Guerrieri-Gonzaga, Sara Gandini
International Journal of Epidemiology|April 17, 2014
Circulating adiponectin and breast cancer risk: a systematic review and meta-analysisDebora Macis, Aliana Guerrieri-Gonzaga, Sara Gandini
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
Is it time to test metformin in breast cancer clinical trials?Massimiliano Cazzaniga, Bernardo Bonanni, Aliana Guerrieri-Gonzaga, et al.
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Massimiliano Cazzaniga, Clara Varricchio, Chiara Montefrancesco, et al.
Breast (Edinburgh, Scotland)|June 2, 2017
Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone usersGabriella Rondanina, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Pharmacological prevention of breast cancer: quo vadis?Davide Serrano, Bernardo Bonanni, Massimiliano Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Pigment Cell & Melanoma Research|October 11, 2012
Vitamin D and overall mortalityAliana Guerrieri-Gonzaga, Sara Gandini
International Journal of Epidemiology|April 17, 2014
Circulating adiponectin and breast cancer risk: a systematic review and meta-analysisDebora Macis, Aliana Guerrieri-Gonzaga, Sara Gandini
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
Is it time to test metformin in breast cancer clinical trials?Massimiliano Cazzaniga, Bernardo Bonanni, Aliana Guerrieri-Gonzaga, et al.
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Massimiliano Cazzaniga, Clara Varricchio, Chiara Montefrancesco, et al.
Breast (Edinburgh, Scotland)|June 2, 2017
Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone usersGabriella Rondanina, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Pharmacological prevention of breast cancer: quo vadis?Davide Serrano, Bernardo Bonanni, Massimiliano Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Pageof 9